P. Scigalla

5.4k citations
82 papers · 3.7k indexed · 1 hit paper · h-index 24

Impact in

  • Hematology top 0.5%
    • Erythropoietin and Anemia Treatment
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%
    • Hemoglobinopathies and Related Disorders

Papers in

    • Erythropoietin and Anemia Treatment 46
    • Acute Myeloid Leukemia Research 7
    • Blood transfusion and management 13

P. Scigalla

73 papers receiving 3.5k citations

Hit Papers

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer 2005 · 934 citations
9342005202620122019250500750

Peers

P. Scigalla
Comparison fields: 5 of 101
  • Hematology 1.7k
  • Genetics 705
  • Biochemistry 314
  • Nephrology 310
  • Cancer Research 594
Replace Ralph V. Boccia with:
Ralph V. Boccia United States
Peter Barrett‐Lee United Kingdom
Eva Lengfelder Germany
Yan Sun China
Brian Kabat United States
Iulia Cristina Tudor United States
Giorgio Massimini Italy
Julie Hambleton United States
Ralph Levitt United States
Kari G. Rabe United States
P. Scigalla relative to Ralph V. Boccia United States Ralph V. Boccia's profile →
Citations per field
00.5×4.3×
Ralph V. Boccia · 1×
Citations per year

Countries citing papers authored by P. Scigalla

Since Specialization
Citations

This map shows the geographic impact of P. Scigalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Scigalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Scigalla more than expected).

Fields of papers citing papers by P. Scigalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Scigalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Scigalla. The network helps show where P. Scigalla may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P. Scigalla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Scigalla Line = papers co-authored together P. Scigalla links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201928
2 20150
3 20150
4 20154
5 20152
6 20151
7 20150
8 20152
9 20150
10 20153
11 201112
12 20092
13 20059
14 200380
15 200213
16 199415
17 1994206
18 19904
19 19909
20 19880

About P. Scigalla

P. Scigalla is a scholar working on Hematology, Biochemistry, Nephrology, Health Informatics and Genetics, having authored 82 papers that have together received 3.7k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (46 papers), Dialysis and Renal Disease Management (14 papers), Blood transfusion and management (13 papers), Pharmacological Effects and Toxicity Studies (9 papers), Acute Myeloid Leukemia Research (7 papers), Hemoglobinopathies and Related Disorders (7 papers), Erythrocyte Function and Pathophysiology (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). The work is most often cited by research in Hematology (1.7k citations), Genetics (705 citations), Biochemistry (314 citations), Nephrology (310 citations) and Cancer Research (594 citations). P. Scigalla has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Carlo L. Bello, Nicoletta Brega, Giorgio Massimini, Éric Raymond, Catherine Delbaldo, Caroline Robert, Jean‐Pierre Armand, Karina Vera, Nathalie Lassau and Sandrine Faivre. Their work appears in journals such as Journal of Clinical Oncology, Blood, Blood Purification, Artificial Organs and Acta Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026